REPORT HIGHLIGHT
Transcutaneous Oximetry Systems Market size was valued at USD 290.6 Million in 2022, expanding at a CAGR of 6.6% from 2023 to 2030.
The only way to assess the local oxygen released from capillaries via the skin and represent the metabolic status of the lower leg is by using transcutaneous oximetry (tcpO2). It is very helpful for predicting wound healing and determining eligibility for hyperbaric oxygen therapy. Additionally, research has demonstrated that when combined with other clinical measures, the score is therapeutically useful for determining the likelihood that patients undergoing amputation would recover their wounds. Transcutaneous oximetry is also advised for CLTI patients as a way to gauge the degree of ischemia and stratify prognosis. It is particularly helpful for identifying PAD in patients with calcified arteries and severed toes.
Transcutaneous Oximetry Systems Market- Market Dynamics:
- Growing utilization in peripheral vascular disorders and diabetic foot ulcers drives the market growth.
- The market is anticipated to develop as a result of the increased use of transcutaneous oximetry devices to diagnose peripheral vascular diseases. For instance, according to the study reported in the paper published in November 2022 in PubMed, transcutaneous oximetry (TcpO2) can be utilized to identify upper limb artery compression and/or symptoms during arm abduction in patients with suspected thoracic outlet syndrome (TOS). Transcutaneous oximetry technologies are also becoming more common to determine whether an amputation is necessary. The most common reason for foot amputation is a diabetic foot ulcer. According to a National Center for Biotechnology Information article from August 2022, diabetic foot ulcers are one of the most common complications of people with diabetes mellitus and can be caused by poor glycemic control, underlying neuropathy, peripheral vascular disease, or inadequate foot care. Neuropathy affects around 60% of diabetics and finally results in a foot ulcer. Between 9.1 and 26.1 million diabetic foot ulcers occur each year worldwide. A diabetic foot ulcer is likely to appear in 15 to 25% of people with diabetes mellitus during the span of their lives. Thereby, driving the market growth over the forecast period.
Transcutaneous Oximetry Systems Market- Key Insights:
- Transcutaneous Oximetry Systems provide non-invasive continuous monitoring of oxygen tension in tissue.
- As per the analysis shared by our research analyst, the global Transcutaneous Oximetry Systems market is estimated to grow annually at a CAGR of around 6.6% over the forecast period (2023-2030)
- Transcutaneous oximetry systems are experiencing advancements in sensor technology, leading to more accurate and reliable measurements. Improved sensor designs and signal processing techniques contribute to enhanced data quality.
- Transcutaneous oximetry systems are being integrated into telemedicine platforms, allowing real-time data transmission and analysis. This integration facilitates timely intervention and decision-making by healthcare professionals.
Transcutaneous Oximetry Systems Market- Segmentation Analysis:
- The Global Transcutaneous Oximetry Systems Market is segmented based on Channel Type, End User, Application, and Region.
- In terms of channel type, Based on application, the global Transcutaneous Oximetry Systems market is segmented into Peripheral Vascular Disorders, Diabetic Foot Ulcers, Preterm Births and Others. Preterm births are expected to grow at the fastest CAGR over the forecast period. The growth in the segment is owing to the rise in preterm deliveries worldwide, which puts vulnerable premature infants in the NICU in danger of abrupt fluctuations in oxygenation and carbon dioxide levels, which can result in serious consequences. Neonatal transcutaneous monitoring offers a real-time snapshot of the patient's often variable breathing (tcpCO2) and oxygenation (tcpO2) state. For instance, according to the WHO's November 2022 report, an estimated 15 million infants are delivered prematurely each year (before 37 full weeks of gestation). Thus, the aforementioned facts drive segment expansion.
Transcutaneous Oximetry Systems Market- Geographical Insights:
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period due to variables including a rise in preterm deliveries, a frequency of peripheral vascular illnesses, problems with wound healing, and a boom in research and development in the area. In 2021, for example, the prevalence of preterm birth among African American women (14.8%) was almost 50% greater than the rate of preterm birth among white or Hispanic women (9.5% and 10.2%, respectively), according to the CDC's November 2022 release. One in ten babies born in the US in 2021 suffered from preterm birth. Therefore, drive the market growth in the region.
Transcutaneous Oximetry Systems Market- Competitive Landscape:
The market for transcutaneous oximetry systems is highly competitive. Market leaders have built their positions in the market due to greater distribution networks and more research funding. The top producers of transcutaneous oximetry devices include, among others, Perimed, SenTec AG, Radiometer, and Cephalon.
Recent Developments:
In February 2022, the TCM5 Flex Transcutaneous Monitor has been added to Compumedics' extensive lineup of sleep diagnostic products in partnership with Radiometer Pacific. In Australia and New Zealand, Compumedics became TCM 5 Flex's authorized distributor.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TRANSCUTANEOUS OXIMETRY SYSTEMS MARKET KEY PLAYERS
- Cephalon
- Perimed AB
- SenTec AG
- medicap
- Advin Health Care
- Radiometer
- DiabetikFoot Care
- Masimo
- Medtronic
GLOBAL TRANSCUTANEOUS OXIMETRY SYSTEMS MARKET, BY CHANNEL TYPE
- Single Channel
- Multichannel
GLOBAL TRANSCUTANEOUS OXIMETRY SYSTEMS MARKET, BY END USER
GLOBAL TRANSCUTANEOUS OXIMETRY SYSTEMS MARKET, BY APPLICATION
- Peripheral Vascular Disorders
- Diabetic Foot Ulcers
- Preterm Births
- Others
GLOBAL TRANSCUTANEOUS OXIMETRY SYSTEMS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA